Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 2
1991 1
1992 3
1993 1
1996 2
1997 2
1998 2
1999 1
2001 2
2003 1
2004 4
2005 4
2006 12
2007 12
2008 13
2009 11
2010 12
2011 12
2012 9
2013 13
2014 11
2015 13
2016 20
2017 16
2018 8
2019 12
2020 13
2021 9
2022 3
Text availability
Article attribute
Article type
Publication date

Search Results

189 results
Results by year
Filters applied: . Clear all
Page 1
Therapeutic Drug Monitoring of Tacrolimus-Personalized Therapy: Second Consensus Report.
Brunet M, van Gelder T, Åsberg A, Haufroid V, Hesselink DA, Langman L, Lemaitre F, Marquet P, Seger C, Shipkova M, Vinks A, Wallemacq P, Wieland E, Woillard JB, Barten MJ, Budde K, Colom H, Dieterlen MT, Elens L, Johnson-Davis KL, Kunicki PK, MacPhee I, Masuda S, Mathew BS, Millán O, Mizuno T, Moes DAR, Monchaud C, Noceti O, Pawinski T, Picard N, van Schaik R, Sommerer C, Vethe NT, de Winter B, Christians U, Bergan S. Brunet M, et al. Among authors: picard n. Ther Drug Monit. 2019 Jun;41(3):261-307. doi: 10.1097/FTD.0000000000000640. Ther Drug Monit. 2019. PMID: 31045868 Review.
Personalized Therapy for Mycophenolate: Consensus Report by the International Association of Therapeutic Drug Monitoring and Clinical Toxicology.
Bergan S, Brunet M, Hesselink DA, Johnson-Davis KL, Kunicki PK, Lemaitre F, Marquet P, Molinaro M, Noceti O, Pattanaik S, Pawinski T, Seger C, Shipkova M, Swen JJ, van Gelder T, Venkataramanan R, Wieland E, Woillard JB, Zwart TC, Barten MJ, Budde K, Dieterlen MT, Elens L, Haufroid V, Masuda S, Millan O, Mizuno T, Moes DJAR, Oellerich M, Picard N, Salzmann L, Tönshoff B, van Schaik RHN, Vethe NT, Vinks AA, Wallemacq P, Åsberg A, Langman LJ. Bergan S, et al. Among authors: picard n. Ther Drug Monit. 2021 Apr 1;43(2):150-200. doi: 10.1097/FTD.0000000000000871. Ther Drug Monit. 2021. PMID: 33711005 Review.
Becquemont L, Picard N, Verstuyft C. Becquemont L, et al. Among authors: picard n. Therapie. 2017 Apr;72(2):173-174. doi: 10.1016/j.therap.2017.01.004. Epub 2017 Jan 30. Therapie. 2017. PMID: 28238399 No abstract available.
MeCP2: an epigenetic regulator of critical periods.
Picard N, Fagiolini M. Picard N, et al. Curr Opin Neurobiol. 2019 Dec;59:95-101. doi: 10.1016/j.conb.2019.04.004. Epub 2019 Jun 1. Curr Opin Neurobiol. 2019. PMID: 31163286 Review.
[Pharmacogenetics for patient care in France: A discipline that evolves!].
Barin-Le Guellec C, Picard N, Alarcan H, Barreau M, Becquemont L, Quaranta S, Boyer JC, Loriot MA; réseau national de pharmacogénétique (RNPGx). Barin-Le Guellec C, et al. Among authors: picard n. Therapie. 2020 Sep-Oct;75(5):459-470. doi: 10.1016/j.therap.2019.09.006. Epub 2019 Oct 30. Therapie. 2020. PMID: 31767126 Review. French.
[COVID-19, management, therapeutic and vaccine approaches].
Matusik É, Ayadi M, Picard N. Matusik É, et al. Among authors: picard n. Actual Pharm. 2020 Oct;59(599):27-33. doi: 10.1016/j.actpha.2020.08.007. Epub 2020 Aug 21. Actual Pharm. 2020. PMID: 32863556 Free PMC article. French.
Imaging the premotor areas.
Picard N, Strick PL. Picard N, et al. Curr Opin Neurobiol. 2001 Dec;11(6):663-72. doi: 10.1016/s0959-4388(01)00266-5. Curr Opin Neurobiol. 2001. PMID: 11741015 Review.
189 results